Search

23 Feb 2024: Jess’ research has led to the launch of a clinical trial, which is testing a new treatment to slow down the […]. Filed Under:5th June 2019. Results indicate that early treatment ... MRC Clinical Director He joins the senior management team and will

23 Feb 2024: Quick Links. For staff. For alumni. For business. Colleges & departments. Libraries & facilities. Museums & collections. Email & phone search. Site Search. Site Search. Cambridge Philosophical Society Lecture Monday 27th February. Department of

23 Feb 2024: Department of Clinical Neurosciences. Featured news. ‘Biohybrid’ device could restore function in paralysed limbs. ... Filed Under: Featured news.

23 Feb 2024: We enable everyone in the UK to participate in the most crucial research, and we reduce healthcare inequalities. ... To consent to approved research being done at their hospital using their existing information.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. ... This new research is a major milestone in our plan to stop MS and we’re incredibly excited about the potential it’s shown for future studies.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Publications. Six months of bexarotene reduces the VEP latency, implying remyelination (Brown Lancet Neurol 2021). ... PMID: 36116011; PMCID: PMC9539389. Needham EJ, …. Coles AJ, Menon DK; Cambridge

23 Feb 2024: Declan Chard, Principal Clinical Research Associate at UCL Queen Square Institute of Neurology. ... Tomas Kalincik, Professor, Head of the Clinical Outcomes Research (CORe) Unit, University of Melbourne.

23 Feb 2024: Horvath Laboratory. Natalia Malig. Natalia Malig. Research Assistant. Natalia is a Research Assistant in the group of prof. ... Hannah Monyer at DKFZ. Ever since, she has a strong interest in the topic and aspires to continue research as an MPhil student.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. FDA warning: stroke after alemtuzumab.

23 Feb 2024: For more details see our website for Clinical MS Research.

23 Feb 2024: themes. This vibrant and multidisciplinary research environment comprises:. the John van Geest Centre for Brain Repair,. ... trials. We are UK pioneers in linking imaging research with electronic healthcare records.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Alemtuzumab (Lemtrada). The history of alemtuzumab use in multiple sclerosis.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. CCMR2 Trial will start in March 2022. ... Check this website for further details near the time. Filed Under: News.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Children with MS. We are exploring changes in myelin and nerve health over time in children with demyelinating diseases, such as multiple sclerosis (MS).

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Cambridge Centre for Myelin Repair. Alasdair Coles leads the Cambridge Centre for Myelin Repair, alongside Prof. ... CCMR is accompanied by the MS Society Edinburgh Centre for MS Research in the journey to

23 Feb 2024: Neurotrauma research within Neurosurgery and Anaesthesia aim to improve the understanding of the mechanisms of brain injury to develop novel treatment strategies that improving the clinical outcome. ... We are strongly committed to improve outcomes in

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Ageing in Multiple Sclerosis (McMurran Group).

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Non-disabling relapses count too! 6th March 2023.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. ‘Digital mask’ could protect patients’ privacy in medical records. ... shared. Filed Under: Featured news.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Understanding Studies. Please see below for further details on our studies that aim to further understanding of mitochondrial and neurodegenerative diseases.